SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-006969
Filing Date
2022-11-01
Accepted
2022-11-01 17:17:32
Documents
15
Period of Report
2022-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_110122.htm   iXBRL 8-K 31810
2 EXHIBIT 99.1 exh_991.htm EX-99.1 22195
6 GRAPHIC cingal.jpg GRAPHIC 33286
7 GRAPHIC graph.jpg GRAPHIC 46264
  Complete submission text file 0001171843-22-006969.txt   392794

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE anik-20221101.xsd EX-101.SCH 3218
4 XBRL LABEL FILE anik-20221101_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE anik-20221101_pre.xml EX-101.PRE 22353
9 EXTRACTED XBRL INSTANCE DOCUMENT f8k_110122_htm.xml XML 3486
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 221351485
SIC: 3841 Surgical & Medical Instruments & Apparatus